Schaeffer Orlov S Nicole's Form 4 filing
INSMED Inc (INSM) · filed Feb 7, 2025
- Accession no.
- 0001628280-25-004464
- Filed
- Feb 7, 2025
- Trade date
- Feb 5-6, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market sales total $1.90M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Schaeffer Orlov S NicoleCIK 0001401017 | Officer (Chief People Strategy Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 5, 2025 | Common Stock | AGrant or awardAcquired | +47,295 | $0.00 | $0 | 144,378 | Direct | |
| Feb 6, 2025 | Common Stock | SSaleDisposed | −23,500 | $80.90F3 | −$1,901,150 | 120,878 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
This is the weighted average sales price representing 23,500 shares sold at prices ranging from $80.57 to $81.43 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
Referenced by the price of 1 transaction in Table I.